Our study uncovers mechanisms of MANF action and provides a foundation for pharmacological strategies that target MANF, which may have profound therapeutic potential to ameliorate kidney fibrosis and slow down kidney function decline in ADTKD-UMOD. The gene discussed is MANF; the disease is autosomal dominant medullary cystic kidney disease with or without hyperuricemia.